Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle. (2016)
Attributed to:
CIMA: The Centre for Integrated Research into Musculoskeletal Ageing
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1096/fj.201600450r
PubMed Identifier: 27550965
Publication URI: http://europepmc.org/abstract/MED/27550965
Type: Journal Article/Review
Volume: 30
Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Issue: 11
ISSN: 0892-6638